Further in a mega-analysis of #adalimumab for all indications the risk of mortality was not increased in ADA treated patients versus the general population and observed deaths was below what would be expected in an age- and sex-adjusted population. https
1,814 followers
398 followers
Mabs and Nibs. There is a general tendency to attribute immune mechanisms and thereby Repurpose biological agents for a variety of medical conditions is proposed. Risk of malignancies in people treated with adalimumab. https://t.co/nlrkeaAThu https://t.co/
791 followers
#adalimumab safety data from 77 clinical trials and nearly 30k trial participants! https://t.co/YiTvTIQTPW https://t.co/NvbzP8NeMJ
1,433 followers
Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis. - PubMed - NCBI; https://t.co/BwKi5cSvbd; treatment for #hidradenitissuppurativa #hs (and other conditions)